The U.S. Food and Drug Administration approved an ovarian cancer drug for the maintenance and treatment of pancreatic cancer, according to AstraZeneca and Merck.
Some deadly diseases that seemed headed for eradication in recent decades have been making a scary comeback in the past 10 years.
Ubrogepant, a new class of drug to treat acute migraine attacks, shows promise to treat patients who have previously lacked other options.
Open Enrollment has begun. Over the next month, millions of Americans will choose their health insurance coverage for 2020. A human resources consultant says it's important to get started, compare your options, and pick the right plan for you.